Welcome to Vivasuite!

Home - Marketing

Welcome to Vivasuite!

Vivasuite | The Digital Ecosystem for Vivalytic

Connectivity at the Point of care

 

 

Welcome to Vivasuite!

 

Enabling the management of multiple devices remotely, Vivasuite is the digital healthcare ecosystem  allowing users to stay up to date with the latest tests and system updates.

Register your interest

Running within the Bosch IoT cloud maintaining the highest standard of IT security and data privacy. Connectivity ensures that devices are always available and fully updated.

 

 

Advantages of Vivasuite:

 

– Schedule remote software updates

– Know when your devices were last synchronised

– View all devices in one dashboard

– View device information and general device data

View testing history from one system

– Mobile device monitoring

– Vivalytic user management

– Save time with less “on-device” work

Vivalytic Overview

Discover more about the Vivalytic

 

 


Vivalytic Resource Hub

Vivalytic | Resource Hub

Making a Point to Care

 

  • Brochures
  • Flyers
  • Videos
  • Scientific Papers

Vivalytic

VIVALYTIC MG, MH UP/UU Educational Guide

VIVALYTIC MRSA/SA Educational Guide

Vivalytic Gastroenteritis Educational Guide

Vivalytic Bordetella Edu guide Cover

VIVALYTIC Bordetella Detection & Species Identification Educational Guide

Vivalytic Overview

Discover more about the Vivalytic

 

 

SARS-CoV-2 Dual Target, Flu A/B and RSV

SARS-CoV-2 Dual Target

MPXV (Monkeypox)

Urinary Tract Infection (UTI)

Candida auris

Viral Respiratory Infection Array

Sexually Transmitted Infection Array

C. difficile

Bacterial Meningitis

riTA CT/NG

SARS-CoV-2 Pooling Test

MG, MH, UP/UU Rapid Test

Norovirus

Bordetella

SARS-CoV-2 Rapid Test

MRSA & MSSA Rapid Test

Rota-, Norovirus & C. difficile

Strep A

Randox Vivalytic

Vivalytic Installation & Operator User Guide

Vivalytic: Instructional Promo Video

Vivalytic: COVID-19 Testing Process

Coronavirus Testing on the Vivalytic POC Analyser

EVALUATION OF A MULTIPLEX REAL-TIME PCR ASSAY FOR THE DIAGNOSIS OF SEXUALLY-TRANSMITTED INFECTIONS

RAPID AND ACCURATE DETECTION OF MYCOPLASMATACEAE IN CLINICAL SAMPLES

Rapid and Accurate Detection of Whooping Cough in Clinical Samples

Evaluation of the Vivalytic one Analyser for detecting uropathogenic bacteria and antimicrobial resistances in urine samples of urological patients


Randox QC Resource Hub

  • Brochures
  • Support Tools
  • Educational Items
  • Posters
  • Industry Articles
  • Webinars
  • Videos
  • Blog
  • Testimonials
The importance of third party controls brochure on the Randox Resource hub

Importance of Third Party Controls

Infectious Disease Controls (Serology)

IQC - Liquid 30 Day Controls

RIQAS Point of Care (RIQAS POC)

Qnostics - Molecular Infectious Disease Controls

QCMD - EQA for Molecular Infectious Disease Testing

International Brochures

Download our brochures in other languages

Serum Indices

The Role of Six Sigma in a Modern QC Strategy

The Cost of Poor Quality in the Clinical Laboratory

How to Establish QC Reference Ranges

Basic QC Statistics

ISO 15189 Requirements for Measurement Uncertainty

Commutability

The Role of EQA in QC

Designing An Appropriate QC Design Procedure

Troubleshooting QC Errors

What Format Is Best For Your Laboratory - Download

What Format Is Best For Your Laboratory

Quality Control for POCT - Download

Quality Control for POCT

Importance of Third Party Controls in Molecular Infectious Disease Testing

Which QC is The Right QC - Downloads

Which QC is The Right QC

How Often Is Right For QC - Download

How Often Is Right For QC

QC Statistics Infographic - Download

QC Statistics Infographic

The Difference Between IQC & EQA - Download

The Difference Between IQC & EQA

Linearity Verification Clinical Chemistry - Download

Linearity Verification Clinical Chemistry

Linearity Verification Cardiac - Download

Linearity Verification Cardiac

Using QC Multi-rules - Download

Using QC Multi-Rules

Preparing QC - Step-by-Step Guide - Download

Preparing QC - Step-by-Step Guide

Monitoring EQA Performance - Download

Monitoring EQA Performance

Guide to Running QC - Download

Guide to Running QC

RIQAS Frequency - Lipase

RIQAS Past Panels Flyer

Measurement Uncertainty in the Clinical Laboratory – Medical Buyer

Measurement Uncertainty in the Clinical Laboratory – Medical Buyer

Using Sigma metrics and Measurement Uncertainty in QC – MLO

Using Sigma metrics and Measurement Uncertainty in QC – MLO

RIQAS Report Interpretation

The Role of EQA in QC Management

Importance of EQA

RIQAS Reporting

Utilisation of QC Software for Identification of Performance Issues

Importance of Third Party Controls in Molecular Diagnostics

The Need for Robust Molecular Quality Assurance in the Wake of the Pandemic

Acusera 24•7 Webinar: Utilisation of QC software and metrics to help identify performance issues

Medlab- 24.7 Webinar with Patrick Else

Why is the third party QC important for COVID-19 detection in Molecular testing

SARS-CoV-2 Proficiency Testing

Performance & Statistics - How EQA Can Help You Excel

Smartdocs - How To Guide

Acusera Third Party Controls

True Third Party Controls

Randox Acusera Quality Controls

Consolidation

QC Serology Video

Acusera 24.7 Live Online

Guide to Running Quality Control

Medical Lab Professionals Week 2016

Acusera 24•7 Interlaboratory Data Management

Acusera 247 Video

Customer Testimonial | Adrian Cudmore NHS

Customer Testimonial | DR Caje Moniz NHS

Customer Testimonial | Dr Rosa Sierra Amor

Customer Testimonial | Dr Bianca Thakkar

Customer Testimonial | Dr. Anil Shah

Customer Testimonial | Dr Pragati Desai

Customer Testimonial | Dr Pramod Ingale

Customer Testimonial | Dr Rajeev Mehta

Customer Testimonial | Dr Simple Bhuptani

Customer Testimonial | Dr SM Patel

Customer Testimonial | Dr Trupti Patel

Customer Testimonial | Dr A Vahed Mulla


Evidence Series Resource Hub

Evidence Series | Resource Hub

  • Brochures
  • Flyers
  • Videos
  • Blogs
  • Scientific Posters
  • Whitepapers

Evidence

Evidence Investigator

Evidence MultiSTAT

Evidence+

Evidence Evolution

Biochip Technology Explained

Evidence series Overview

Discover more about the Evidence series

 

Cytokines Flyer

DIKI Renal Flyer

A4 Renal Flyer

AKI Covid-19 Flyer

Evidence Investigator - Molecular Diagnostic Testing

Evidence MultiSTAT Demonstration

Evidence Evolution - World's Most Advanced Immunoanalyser

Evidence Investigator - Myco 9 Array, Step By Step

DEVELOPMENT OF A BIOCHIP ARRAY FOR THE SIMULTANEOUS DETECTION OF CANCER BIOMARKERS ON THE RANDOM ACCESS, FULLY AUTOMATED EVIDENCE EVOLUTION ANALYSER

DEVELOPMENT OF A DUPLEX BIOCHIP ASSAY FOR THE SIMULTANEOUS DETECTION OF ANTI-THYROGLOBULIN AND ANTI-THYROID PEROXIDASE ANTIBODIES ON THE FULLY AUTOMATED EVIDENCE EVOLUTION ANALYSER

DEVELOPMENT OF NEW BIOCHIP ARRAYS FOR THE DETERMINATION OF BIOMARKERS RELATED TO ACUTE KIDNEY INJURY APPLIED TO THE EVIDENCE INVESTIGATOR ANALYSER

DEVELOPMENT OF A NEW BIOCHIP BASED IMMUNOASSAY FOR THE DETECTION OF PARATHYROID HORMONE APPLIED TO THE EVIDENCE EVOLUTION ANALYSER

DEVELOPMENT OF A HIGHLY MULTIPLEXED MOLECULAR ASSAY FOR DETECTION OF INFECTION IN CF AIRWAYS

Repeatability and within-laboratory precision were assessed (n=80): Assay Repeatability Within-laboratory precision CV (%) CV (%) VCAM-1 4.5 6.8 ICAM-1 5.6 8.8 ESEL 12.8 16.6 PSEL 3.5 4.7 LSEL 5.7 8.2 17.096, 097.105RDRT DEVELOPMENT OF A BIOCHIP ARRAY FOR THE DETECTION OF ADHESION MOLECULES ON THE NEW RANDOM ACCESS FULLY AUTOMATED EVIDENCE EVOLUTION ANALYSER

DEVELOPMENT OF A NEW BIOCHIP BASED IMMUNOASSAY UNAFFECTED BY DHEA-S INTERFERENCE FOR THE ACCURATE MEASUREMENT OF SERUM PROGESTERONE

DEVELOPMENT OF A BIOCHIP ARRAY FOR THE RAPID, SIMULTANEOUS DETECTION OF PEPSINOGEN I, PEPSINOGEN II AND GASTRIN 17, ON THE NEW RANDOM ACCESS, FULLY AUTOMATED EVIDENCE EVOLUTION ANALYSER

CLINICAL EVALUATION OF A RAPID FULLY-AUTOMATED MULTIPLEX BIOCHIP ARRAY FOR STROKE DIAGNOSIS

DEVELOPMENT OF A NEW BIOCHIP ARRAY APPLIED TO THE NEW RANDOM ACCESS FULLY AUTOMATED EVIDENCE EVOLUTION ANALYSER FOR THE SIMULTANEOUS MEASUREMENT OF TSH, FREE T4 AND FREE T3

DEVELOPMENT OF A NEW BIOCHIP BASED IMMUNOASSAY FOR THE MEASUREMENT OF TOTAL 25-HYDROXYVITAMIN D IN SERUM AND THE ACCURATE CLASSIFICATION OF VITAMIN D STATUS

DEVELOPMENT OF A BIOCHIP ASSAY FOR THE DETECTION OF THYROXINE-BINDING GLOBULIN (TBG) ON THE NEW RANDOM ACCESS FULLY AUTOMATED EVIDENCE EVOLUTION ANALYSER

GENETIC DIAGNOSIS OF MONOGENIC OR POLYGENIC FAMILIAL HYPERCHOLESTEROLEMIA IN NORTHERN IRELAND: EVALUATION OF THE RANDOX FH ARRAYS IN COMBINATION WITH THE RANDOX 6SNP POLYGENIC HYPERCHOLESTEROLEMIA ARRAY

DEVELOPMENT OF A BIOCHIP ARRAY FOR THE SIMULTANEOUS MEASUREMENT OF DISTINCT FATTY ACID-BINDING PROTEINS (FABPs)

DEVELOPMENT OF A NEW ENZYME-LINKED IMMUNOSORBENT ASSAY KIT TO DETECT NGAL IN HUMAN SERUM AND ITS APPLICATION TO CHRONIC KIDNEY DISEASE

SCREENING AND SELECTION OF ANTIBODIES FOR THE DETECTION OF MIP-1 ALPHA AND ITS APPLICATION TO THE STUDY OF CHRONIC KIDNEY DISEASE

DEVELOPMENT OF A 4-PLEX BIOCHIP ARRAY FOR THE EARLY DETECTION OF CHRONIC KIDNEY DISEASE

DEVELOPMENT OF A THIRD GENERATION TSH ASSAY ON THE NEW RANDOM ACCESS EVIDENCE EVOLUTION FULLY AUTOMATED BIOCHIP ANALYSER

APPLICATION OF THE NEW RANDOM ACCESS, FULLY AUTOMATED BIOCHIP ANALYSER EVIDENCE EVOLUTION TO SIMULTANEOUSLY MEASURE ANALYTES RELATED TO ENDOCRINE FUNCTION

STRATIFYING RISK OF ACUTE KIDNEY INJURY IN PRE AND POST CARDIAC SURGERY PATIENTS USING A NOVEL BIOMARKER-BASED ALGORITHM AND CLINICAL RISK SCORE

SARS-CoV-2 Vascular & Multi-System Dysfunction

Acute Kidney Injury and Antimicrobial Stewardship

Alzheimer's Disease, ApoE4 & Risk Detection


Randox Reagents Resource Hub

Resource Hub | Reagents

  • Brochures
  • Featured Reagents
  • Blogs
  • Webinars
  • Educational Items
Reagents Brochure

Reagents Brochure

Superior Performance & Unique Tests

Veterinary Diagnostic Solutions Brochure

Veterinary Diagnostic Solutions

Diabetes Portfolio Brochure

Diabetes Portfolio

Antioxidants Brochure

Antioxidants

Cardiology & Lipid Testing Brochure

Cardiology & Lipid Testing

Total Bile Acids Flyer

Total Bile Acids (5th Generation)

Specific Proteins Brochure

Specific Proteins

sdLDL-C Flyer

sdLDL-C

sdLDL-C Flyer

sdLDL-C (USA ONLY)

Reagents Brochure

Reagents Brochure - Spanish

Reagents Brochure

Reagents Brochure - French

Reagents Brochure

Reagents Brochure - Portuguese

Reagents Brochure

Reagents Brochure - Russian

Reagents Brochure

Reagents Brochure - Italian

Reagents Brochure

Reagents Brochure - Polish

Clinical Considerations in Evaluating Lipid Risk Beyond LDL-C

Presenter: Christie M Ballantyne, MD

Navigating the Gray Area of Atherosclerotic Risk Stratification A Roundtable Discussion

Navigating the Gray Area of Atherosclerotic Risk Stratification

Small-Dense LDL and Cardiovascular Disease

Cystatin C Whitepaper

Cystatin C

Early Risk Assessment of Renal Impairment using the Biomarker Cystatin C

OVERCOMING THE CURRENT CHALLENGES IN LP(A) MEASUREMENT

Lipoprotein(a)

Overcoming The Current Challenges in Lp(a) Measurement

sdLDL-C

Size Matters: The True Weight of Risk in Lipid Profiling